by Chris Hitchcock | Sep 8, 2010 | Menstruation
An open-access article published in PLOS Medicine yesterday, Dr. Adriane Fugh-Berman, associate professor in the Department of Physiology at Georgetown University Medical Center in Washington DC, presents an article describing the ways in which the pharmaceutical...
by Elizabeth Kissling | May 7, 2010 | Birth Control, Pharmaceutical
In the flood of media commemorating the 50th anniversary of FDA approval of the birth control pill, this story from the Washington Post about its newest iteration may just slide under your radar: FDA approves new birth control pill from Bayer. Bayer, as you may...
by Elizabeth Kissling | Apr 6, 2010 | Law/Legal, Philosophy
Guest Post by Barbara A. Brenner Executive Director, Breast Cancer Action One of the saddest aspects of capitalism is that companies think they can and should own anything they get their hands on. Some time ago, they started obtaining patents on human genes, including...
by Elizabeth Kissling | Dec 18, 2009 | Health Care, Law/Legal, Menopause, Pharmaceutical
You may have heard the news that 23 hormone replacement therapy lawsuits filed by women diagnosed with breast cancer were dismissed by a New York judge this week. Judge Martin Shulman granted Pfizer’s motion to dismiss for two reasons: the plaintiff’s...
by Elizabeth Kissling | Dec 16, 2009 | Internet, Law/Legal, Media, Menopause, Pharmaceutical
That was Zoe Littlepage’s response to Pfizer’s request to a judge that her law firm remove this video press release about Pfizer’s malfeasance regarding cancer risk of Prempro, their menopause hormone therapy drug. The motion reads, in part,...
